XML 62 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Other-than-temporary impairments                     $ 0   $ 0 $ 0 $ 0
Advance Medicare payments to provide relief from economic impacts of COVID-19                         29,700,000    
Revenue, remaining performance obligation $ 11,200,000                   11,200,000        
Decrease in revenue due to changes in estimated transaction price due to contractual adjustments                         9,900,000    
Accrued liability for Medicare refund 18,400,000   $ 14,100,000       $ 18,000,000.0       18,400,000   14,100,000 18,000,000.0  
Revenues 154,600,000 $ 145,200,000 93,200,000 $ 164,000,000.0 $ 195,100,000 $ 186,300,000 $ 215,400,000 $ 216,600,000 $ 216,800,000 $ 202,300,000 299,800,000 $ 381,400,000 638,600,000 $ 851,100,000 $ 743,700,000
Capitalized costs incurred to obtain or fulfill contract $ 0                   $ 0        
Provider fund relief under CARES Act                         $ 14,600,000    
Immaterial prior period Medicare claims                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Change in earnings (loss) per share (dollars per share)                         $ (0.05)    
Immaterial prior period Medicare claims | Diagnostic                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Accrued liability for Medicare refund     $ 4,700,000                   $ 4,700,000    
Revenues                         $ (4,700,000)    
Performance obligation estimate                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Change in earnings (loss) per share (dollars per share)                         $ (0.10)    
Equipment | Minimum                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Estimated useful lives (in years)                     5 years        
Equipment | Maximum                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Estimated useful lives (in years)                     7 years        
Leasehold improvements | Minimum                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Estimated useful lives (in years)                     1 year        
Leasehold improvements | Maximum                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Estimated useful lives (in years)                     7 years        
Medicare | Revenue                              
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]                              
Concentration risk (percent)                     16.00%   15.00% 14.00% 17.00%